Clinical safety and efficacy of probiotic administration following burn injury

Journal of Burn Care and Research

Volumn 36, Issue 1, 2015, Pages 92-99

  Mayes, Theresa ^a,b   Gottschlich, Michele M ^a,c   James, Laura E ^a   Allgeier, Chris ^a   Weitz, Julie ^a   Kagan, Richard J ^a,c  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; LAXATIVE; PLACEBO; PROBIOTIC AGENT;

ADOLESCENT; ARTICLE; BURN; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LENGTH OF STAY; MALE; NURSING STAFF; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; WOUND CLOSURE; WOUND HEALING; AGE; BURNS; ENTERIC FEEDING; LACTOBACILLUS RHAMNOSUS; PATHOLOGY; PRESCHOOL CHILD; PROSPECTIVE STUDY; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

AGE FACTORS; BURNS; CHILD; CHILD, PRESCHOOL; ENTERAL NUTRITION; FEMALE; HUMANS; LACTOBACILLUS RHAMNOSUS; LENGTH OF STAY; MALE; PROBIOTICS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME; WOUND HEALING;

EID: 84921516243     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0000000000000139     Document Type: Article

References (82)

1. Vighi G, Marcucci F, Sensi L, Di Cara G, Frati F. Allergy and the gastrointestinal system. Clin Exp Immunol 2008;153 (Suppl 1):3-6.
2. Food and Agriculture Organization of the United Nations and World Health Organization. Guidelines for the evaluation of probiotics in food. London, Ontario, Canada, April 30 and May 1, 2002; available from http://www. who. int/ foodsafety/fs-management/en/probiotic-guidelines. pdf; accessed 1 Feb. 2014.
3. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology 2009;136:65-80.
4. Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 2001;73 (2 Suppl):430S-6S.
5. Tuohy KM, Probert HM, Smejkal CW, Gibson GR. Using probiotics and prebiotics to improve gut health. Drug Discov Today 2003;8:692-700.
6. Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut 1998;42:2-7.
7. Holzapfel WH, Haberer P, Snel J, Schillinger U, Huis in't Veld JH. Overview of gut flora and probiotics. Int J Food Microbiol 1998;41:85-101.
8. Wheeler JG, Bogle ML, Shema SJ, et al. Impact of dietary yogurt on immune function. Am J Med Sci 1997;313:120-3.
9. Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr 2000;54:263-7.
10. De Simone C, Vesely B, Salvadori B, et al. The role of probiotics in modulation of the immune system in man and in animals. Int J Immunother 1993;IX:23-8.
11. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 1995;78:491-7.
12. Spanhaak S, Havenaar R, Schaafsma G. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr 1998;52:899-907.
13. Cebra JJ. Influences of microbiota on intestinal immune system development. Am J Clin Nutr 1999;69:1046S-51S.
14. Fukushima Y, Kawata Y, Hara H, Terada A, Mitsuoka T. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 1998;42:39-44.
15. Marteau P, Vaerman JP, Dehennin JP, et al. Effects of intrajejunal perfusion and chronic ingestion of Lactobacillus johnsonii strain La1 on serum concentrations and jejunal secretions of immunoglobulins and serum proteins in healthy humans. Gastroenterol Clin Biol 1997;21:293-8.
16. Malin M, Suomalainen H, Saxelin M, Isolauri E. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab 1996;40:137-45.
17. Nova E, Wärnberg J, Gómez-Martínez S, Díaz LE, Romeo J, Marcos A. Immunomodulatory effects of probiotics in different stages of life. Br J Nutr 2007;98 (Suppl 1):S90-5.
18. Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME. Probiotics and immunity. J Gastroenterol 2009;44:26-46.
19. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006;101:812-22.
20. Szajewski H, Ruszcynski M, Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr 2006;149:367-72.
21. Johnston BC, Supina AL, Ospina M, Vohra S. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2007;2:CD004827.
22. Cremonini F, Di Caro S, Nista EC, et al. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2002;16:1461-7.
23. Johnston BC, Supina AL, Ospina M, Vohra S. Probiotics in the prevention of pediatric antibiotic-associated diarrhea (review). Hoboken, New Jersey: The Cochrane Collaboration, John Wiley and Sons, Ltd; 2008. p. 1-39.
24. Phuapradit P, Varavithya W, Vathanophas K, et al. Reduction of rotavirus infection in children receiving bifidobacteriasupplemented formula. J Med Assoc Thai 1999;82 (Suppl 1):S43-8.
25. Juntunen M, Kirjavainen PV, Ouwehand AC, Salminen SJ, Isolauri E. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin Diagn Lab Immunol 2001;8:293-6.
26. Resta SC. Effects of probiotics and commensals on intestinal epithelial physiology: implications for nutrient handling. J Physiol 2009;587 (Part 17):4169-74.
27. Scholz-Ahrens KE, Ade P, Marten B, et al. Prebiotics, probiotics and symbiotics affect mineral absorption, bone mineral content and bone structure. J Nutr 2007;137:838S-46S.
28. Reid G. Probiotics for urogenital health. Nutr Clin Care 2002;5:3-8.
29. Reid G. Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 2001;73 (2 Suppl):437S-43S.
30. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 2001;30:49-52.
31. Wickens K, Black PN, Stanley TV, et al; Probiotic Study Group. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebocontrolled trial. J Allergy Clin Immunol 2008;122:788-94.
32. Rosenfeldt V, Benfeldt E, Nielsen SD, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003;111:389-95.
33. Viljanen M, Savilahti E, Haahtela T, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 2005;60:494-500.
34. Kalliomaki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomized placebocontrolled trial. Lancet 2001;357:1076-9.
35. Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003;361:1869-71.
36. Björkstén B. Evidence of probiotics in prevention of allergy and asthma. Curr Drug Targets Inflamm Allergy 2005;4:599-604.
37. Rautava S, Kalliomäki M, Isolauri E. New therapeutic strategy for combating the increasing burden of allergic disease: Probiotics-A Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI) Research Group report. J Allergy Clin Immunol 2005;116:31-7.
38. Kirjavainen PV, Apostolou E, Salminen SJ, Isolauri E. New aspects of probiotics-a novel approach in the management of food allergy. Allergy 1999;54:909-15.
39. Majamaa, Isolauri E. Probiotics a novel approach in the management of food allergy. J Allergy Clin Immunol 1997;99:179-185.
40. Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006;101:1581-90.
41. Saggaiori A. Probiotics in the treatment of irritable bowel syndrome. J Clin Gastro Enterol 2004;38:S104-S106.
42. Kajander K, Hatakka K, Poussa T, Färkkilä M, Korpela R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther 2005;22:387-94.
43. Vanderpool C, Yan F, Polk DB. Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis 2008;14:1585-96.
44. Fedorak RN, Madsen KL. Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis 2004;10:286-99.
45. Bin-Nun A, Bromiker R, Wilschanski M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005;147:192-6.
46. Lin HC, Su BH, Chen AC, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005;115:1-4.
47. Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 2007;369:1614-20.
48. Herek O, Kara IG, Kaleli I. Effects of antibiotics and Saccharomyces boulardii on bacterial translocation in burn injury. Surg Today 2004;34:256-60.
49. Wang ZT, Yao YM, Xiao GX, Sheng ZY. [The protective effect of supplementation of probiotics combined with riboflavin on the intestinal barrier of the rats after scald injury]. Zhonghua Shao Shang Za Zhi 2004;20:202-5.
50. Gun F, Salman T, Gurler N, Olgac V. Effect of probiotic supplementation on bacterial translocation in thermal injury. Surg Today 2005;35:760-4.
51. Zhongtang Y, Guangxia X, Yongming Y. The role of bifidobacteria in gut barrier function after thermal injury in rats. J Trauma 2006;61:650-7.
52. Wang ZT, Yao YM, Xiao GX, Cao WH, Sheng ZY. [Bifidobacterial supplement enhances the expression and excretion of intestinal sIgA in severely burned rats]. Zhonghua Wai Ke Za Zhi 2003;41:385-8.
53. Kagan RJ. Burn service survival guide. 6th ed. Cincinnati, Ohio: Shriners Hospitals for Children; 2011.
54. Gottschlich MM, Warden GD, Michel M, et al. Diarrhea in tube-fed burn patients: incidence, etiology, nutritional impact, and prevention. JPEN J Parenter Enteral Nutr 1988;12:338-45.
55. Neely AN, Smith WL, Warden GD. Efficacy of a rise in C-reactive protein serum levels as an early indicator of sepsis in burned children. J Burn Care Rehabil 1998;19:102-5.
56. Kullen MJ, Bettler J. The delivery of probiotics and prebiotics to infants. Curr Pharm Des 2005;11:55-74.
57. Drisko JA, Giles CK, Bischoff BJ. Probiotics in health maintenance and disease prevention. Altern Med Rev 2003;8:143-55.
58. Erickson KL, Hubbard NE. Probiotic immunomodulation in health and disease. J Nutr 2000;130 (2S Suppl):403S-9S.
59. Minocha A. Probiotics for preventive health. Nutr Clin Pract 2009;24:227-41.
60. Goldin BR. Health benefits of probiotics. Br J Nutr 1998;80:S203-7.
61. De Simone C, Vesely R, Bianchi-Salvadori B, Jirillo E. The role of probiotics in modulation of the immune system in man and in animals. Int J Immunother. 1993;9:23-8.
62. Hojsak I, Snovak N, Abdovi S, Szajewska H, Misak Z, Kolacek S. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebocontrolled trial. Clin Nutr 2010;29:312-6.
63. Report of a joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powdered milk and live lactic acid bacteria. Cordoba, Argentina, 2001.
64. Kunz AN, Noel JM, Fairchok MP. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 2004;38:457-8.
65. De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 2005;24:278-80.
66. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005;115:178-81.
67. Richard V, Van der Auwera P, Snoeck R, Daneau D, Meunier F. Nosocomial bacteremia caused by Bacillus species. Eur J Clin Microbiol Infect Dis 1988;7:783-5.
68. Oggioni MR, Pozzi G, Valensin PE, Galieni P, Bigazzi C. Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis. J Clin Microbiol 1998;36:325-6.
69. Lherm T, Monet C, Nougière B, et al. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med 2002;28:797-801.
70. Honeycutt TC, El Khashab M, Wardrop RM III, et al. Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebocontrolled trial. Pediatr Crit Care Med 2007;8:452-8; quiz 464.
71. Whelan K, Myers CE. Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials. Am J Clin Nutr 2010;91:687-703.
72. Koren L, Gurfinkel R, Glezinger R, Perry ZH, Lev-Ari S, Rosenberg L. The effect of Lactobacillus bacteria supplement on sepsis and its complications in patients with acute burns. Burns 2007;33:594-8.
73. Romeo MG, Romeo DM, Trovato L, et al. Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome. J Perinatol 2011;31:63-9.
74. Zwolinska-Weislo M, Brzozwski T, Mach T, et al. Are probiotics effective in the treatment of fungal colonization of the gastrointestinal tract? Experimental and clinical studies. J Physiol Pharmacol 2006;9:35-9.
75. Brzozowki T, Zwolinska-Weislo M, Konturek PC, et al. Influence of gastric colonization with Candida albicans on ulcer healing in rats: effect of ranitidine, aspirin, and probiotic therapy. Scand J Gastroenterol 2005;40:286-96.
76. Falagas ME, Betsi GI, Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J Antimicrob Chemother 2006;58:266-72.
77. Wagner RD, Pierson C, Warner T, et al. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect Immun 1997;65:4165-72.
78. Kühbacher T, Ott SJ, Helwig U, et al. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 2006;55:833-41.
79. Collado MC, Isolauri E, Salminen S, Sanz Y. The impact of probiotic on gut health. Curr Drug Metab 2009;10:68-78.
80. Isolauri E. Probiotics in human disease. Am J Clin Nutr 2001;73:1142S-6S.
81. Isolauri E. The use of probiotics in pediatrics. Br J Hosp Med 2000;61:6-7.
82. Fooks LJ, Gibson GR. Probiotics as modulators of the gut flora. Br J Nutr 2002;88 (Suppl 1):S39-49.